High-dose carboplatin, thiotepa, and etoposide with autologous stem- cell rescue for patients with recurrent medulloblastoma

Journal of Clinical Oncology

Volumn 16, Issue 1, 1998, Pages 222-228

  Dunkel, Ira J ^a   Boyett, James M ^a   Yates, Allan ^a   Rosenblum, Marc ^a   Garvin Jr , James H ^a   Bostrom, Bruce C ^a   Goldman, Stewart ^a   Sender, Leonard S ^a   Gardner, Sharon L ^a   Li, Hao ^a   Allen, Jeffrey C ^a   Finlay, Jonathan L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; ETOPOSIDE; THIOTEPA;

ADOLESCENT; ADULT; ARTICLE; ASPERGILLOSIS; BEAM THERAPY; BONE MARROW RESCUE; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MEDULLOBLASTOMA; MULTIMODALITY CANCER THERAPY; MULTIPLE ORGAN FAILURE; PANCYTOPENIA; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; VEIN OCCLUSION;

EID: 0031982606     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.1.222     Document Type: Article

References (22)

1. Packer RJ, Sutton LN, Goldwein JW, et al: Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 74:433-440, 1991
2. Belza MG, Donaldson SS, Steinberg GK, et al: Medulloblastoma: Freedom from relapse longer than 8 years - a therapeutic cure? J Neurosurg 75:575-582, 1991
3. Torres CF, Rebsamen S, Silber JH, et al: Surveillance scanning of children with medulloblastoma. N Engl J Med 330:892-895, 1994
4. Calvert AH, Newell DR, Gumbrell LA, et al: Carboplatin dosage: Prospective evaluation of a simple formula based on renal function. J Clin Oncol 7:1748-1756, 1989
5. Newell DR, Pearson AD, Balmanno K, et al: Carboplatin pharmacokinetics in children: The development of a pediatric dosing formula. J Clin Oncol 11:2314-2323, 1993
6. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
7. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer 34:585-612, 1976
8. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
9. George D, Ginsberg J, Weingast R, et al: Multiorgan system failure syndrome in patients undergoing myeloablative chemotherapy and autologous bone marrow rescue for malignant brain tumors. Exp Hematol 22:379, 1994 (abstr)
10. Evans AE, Jenkin RDT, Sposto R, et al: The treatment of medulloblastoma: Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 72:572-582, 1990
11. Bailey CC, Gnekow A, Wellek S, et al: Prospective randomized trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Med Pediatr Oncol 25:166-178, 1995
12. Gaynon PS, Ettinger LJ, Baum ES, et al: Carboplatin in childhood brain tumors. A Children's Cancer Study Group Phase II trial. Cancer 66:2465-2469, 1990
13. Friedman HS, Krischer JP, Burger P, et al: Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: A Pediatric Oncology Group randomized phase II study. J Clin Oncol 10:249-256, 1992
14. Heideman RL, Packer RJ, Reaman GH, et al: A phase II evaluation of thiotepa in pediatric central nervous system malignancies. Cancer 72:271-275, 1993
15. Boor R, Huber A, Gutjahr P: Etoposide treatment in recurrent medulloblastoma. Neuropediatrics 25:39-41, 1994
16. Heideman RL, Cole DE, Balis F, et al: Phase I and pharmacokinetic evaluation of thiotepa in the cerebrospinal fluid and plasma of pediatric patients: Evidence for dose-dependent plasma clearance of thiotepa. Cancer Res 49:736-741, 1989
17. Finlay JL, Goldman S, Wong MC, et al: Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. J Clin Oncol 14:2495-2503, 1996
18. Kalifa C, Hartmann O, Vassal G, et al: High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: A phase II study. Bone Marrow Transplant 9:227-233, 1992
19. Dupuis-Girod S, Hartmann O, Benhamou E, et al: Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma? J Neurooncol 27:87-98, 1996
20. Mahoney DH Jr, Strother D, Camitta B, et al: High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: A pilot Pediatric Oncology Group study. J Clin Oncol 14:382-388, 1996
21. Graham ML, Herndon JE III, Casey JR, et al: High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors. J Clin Oncol 15:1814-1823, 1997
22. Gajjar A, Mulhern RK, Heideman RL, et al: Medulloblastoma in very young children: Outcome of definitive craniospinal irradiation following incomplete response to chemotherapy. J Clin Oncol 12:1212-1216, 1994